Patrick W Gould1, Babette S Zemel2, Elena G Taratuta1, Joshua F Baker3. 1. P.W. Gould, BA, E.G. Taratuta, MD, Perelman School of Medicine, University of Pennsylvania. 2. B.S. Zemel, PhD, Perelman School of Medicine, University of Pennsylvania, and Children's Hospital of Philadelphia. 3. J.F. Baker, MD, MSCE, Perelman School of Medicine, University of Pennsylvania, Philadelphia VA Medical Center, Division of Rheumatology, University of Pennsylvania, and Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Joshua.Baker@pennmedicine.upenn.edu.
Abstract
OBJECTIVE: This study evaluated associations between fibroblast growth factor (FGF)-21, an adipokine associated with metabolic stress, and adverse longitudinal changes in body composition and physical functioning in patients with rheumatoid arthritis (RA). METHODS: At baseline and follow-up, patients with RA aged 18-70 years completed whole-body dual-energy X-ray absorptiometry and peripheral quantitative computed tomography to quantify lean mass, fat mass, and muscle density. Dynamometry assessed muscle strength at the hand and knee, and physical functioning was measured with the Health Assessment Questionnaire (HAQ) and the Short Physical Performance Battery (SPPB). FGF-21 and inflammatory cytokines were measured at baseline. Linear and logistic regression analyses assessed associations between FGF-21 levels and both body composition and physical functioning over time. RESULTS: There were 113 patients with RA enrolled, and 84 (74%) returned for follow-up at a median of 2.68 years. At baseline, FGF-21 was associated with age, smoking, methotrexate use, adiposity, and inflammatory cytokines: tumor necrosis factor receptor type I, YKL-40, vascular endothelial growth factor (VEGF), and resistin. The highest FGF-21 quartile was associated with worse SPPB and HAQ. Higher baseline FGF-21 levels (per 1 SD) were associated with worsening in muscle density and area Z-scores (β -0.06, 95% CI -0.12 to 0.008, P = 0.08; and β -0.05, 95% CI -0.10 to 0.006, P = 0.08, respectively) and a greater probability of a clinically meaningful worsening of HAQ (OR 2.37, 95% CI 1.21-4.64, P = 0.01). The fourth FGF-21 quartile was associated with worsening of SPPB (β -0.57, 95% CI -1.04 to -0.09, P = 0.02). CONCLUSION: FGF-21 levels are associated with obesity and inflammatory cytokines, and with worsening in physical functioning in RA. These data support the hypothesis that FGF-21 can identify patients at risk of functional decline.
OBJECTIVE: This study evaluated associations between fibroblast growth factor (FGF)-21, an adipokine associated with metabolic stress, and adverse longitudinal changes in body composition and physical functioning in patients with rheumatoid arthritis (RA). METHODS: At baseline and follow-up, patients with RA aged 18-70 years completed whole-body dual-energy X-ray absorptiometry and peripheral quantitative computed tomography to quantify lean mass, fat mass, and muscle density. Dynamometry assessed muscle strength at the hand and knee, and physical functioning was measured with the Health Assessment Questionnaire (HAQ) and the Short Physical Performance Battery (SPPB). FGF-21 and inflammatory cytokines were measured at baseline. Linear and logistic regression analyses assessed associations between FGF-21 levels and both body composition and physical functioning over time. RESULTS: There were 113 patients with RA enrolled, and 84 (74%) returned for follow-up at a median of 2.68 years. At baseline, FGF-21 was associated with age, smoking, methotrexate use, adiposity, and inflammatory cytokines: tumor necrosis factor receptor type I, YKL-40, vascular endothelial growth factor (VEGF), and resistin. The highest FGF-21 quartile was associated with worse SPPB and HAQ. Higher baseline FGF-21 levels (per 1 SD) were associated with worsening in muscle density and area Z-scores (β -0.06, 95% CI -0.12 to 0.008, P = 0.08; and β -0.05, 95% CI -0.10 to 0.006, P = 0.08, respectively) and a greater probability of a clinically meaningful worsening of HAQ (OR 2.37, 95% CI 1.21-4.64, P = 0.01). The fourth FGF-21 quartile was associated with worsening of SPPB (β -0.57, 95% CI -1.04 to -0.09, P = 0.02). CONCLUSION: FGF-21 levels are associated with obesity and inflammatory cytokines, and with worsening in physical functioning in RA. These data support the hypothesis that FGF-21 can identify patients at risk of functional decline.
Authors: Jody Dushay; Patricia C Chui; Gosala S Gopalakrishnan; Marta Varela-Rey; Meghan Crawley; Ffolliott M Fisher; Michael K Badman; Maria L Martinez-Chantar; Eleftheria Maratos-Flier Journal: Gastroenterology Date: 2010-05-05 Impact factor: 22.682
Authors: Joshua F Baker; Philip G Conaghan; Josef S Smolen; Daniel Aletaha; Justine Shults; Paul Emery; Daniel G Baker; Mikkel Ostergaard Journal: Arthritis Rheumatol Date: 2014-04 Impact factor: 10.995
Authors: Wing Sun Chow; Aimin Xu; Yu Cho Woo; Annette W K Tso; Stephen C W Cheung; Carol H Y Fong; Hung Fat Tse; Ming Tak Chau; Bernard M Y Cheung; Karen S L Lam Journal: Arterioscler Thromb Vasc Biol Date: 2013-07-25 Impact factor: 8.311
Authors: H Hulejová; L Andrés Cerezo; M Kuklová; O Pecha; T Vondráček; K Pavelka; J Vencovský; M Haluzík; L Senolt Journal: Physiol Res Date: 2012-08-08 Impact factor: 1.881
Authors: Gary M Oderda; Grant D Lawless; Grace C Wright; Samuel R Nussbaum; Renwyck Elder; Kibum Kim; Diana I Brixner Journal: Per Med Date: 2018-04-25 Impact factor: 2.512
Authors: Thomas Lang; Jane A Cauley; Frances Tylavsky; Douglas Bauer; Steven Cummings; Tamara B Harris Journal: J Bone Miner Res Date: 2010-03 Impact factor: 6.741
Authors: Miguel Ángel Gómez-Sámano; Mariana Grajales-Gómez; Julia María Zuarth-Vázquez; Ma Fernanda Navarro-Flores; Mayela Martínez-Saavedra; Óscar Alfredo Juárez-León; Mariana G Morales-García; Víctor Manuel Enríquez-Estrada; Francisco J Gómez-Pérez; Daniel Cuevas-Ramos Journal: Redox Biol Date: 2016-12-22 Impact factor: 11.799
Authors: Joshua F Baker; Patricia Katz; David R Weber; Patrick Gould; Michael D George; Jin Long; Babette S Zemel; Jon T Giles Journal: Arthritis Care Res (Hoboken) Date: 2021-09-24 Impact factor: 4.794